Omics technologies in endometriosis research: current evidence and prospects for a multi-omics approach

In: Russian Journal of Human Reproduction · 2026 · vol. 32(5) , pp. 8 · doi:10.17116/repro2026320518 · W7235985563
OA: closed CC0
View on OpenAlex View at publisher

Abstract

Endometriosis is a pathological condition characterized by the presence of tissue morphologically and functionally similar to the endometrium outside the uterine cavity. Its clinical and biological heterogeneity limits the possibility of identifying universal molecular characteristics of the disease and predicting its course in individual patients. The aim of this review is to summarize current evidence on genomic, transcriptomic, proteomic, and metabolomic alterations in endometriosis; to assess the potential of multi-omics integration and the associations of molecular data with clinical, intraoperative, and histopathological characteristics; and to evaluate the prospects for improving diagnosis, predicting disease course, and individualizing patient management. The reviewed studies demonstrate molecular differences associated with the anatomical form of endometriosis, tissue cellular composition and microenvironment, the type of biological material analyzed, and menstrual cycle phase. Integration of data across omics levels enables the identification of biologically consistent molecular alterations and the formulation of hypotheses regarding their functional significance but does not establish causal relationships without experimental validation. Correlating molecular profiles with clinical manifestations, intraoperative findings, and histopathological features may provide a basis for identifying factors associated with the individual course of the disease. The clinical application of molecular markers is limited by small sample sizes, the influence of physiological and preanalytical factors, and insufficient independent validation. Diagnostic models require validation in patient groups with similar clinical symptoms. The prognostic value of molecular markers has not yet been established and requires studies assessing subsequent clinical outcomes. The prospects for multi-omics integration include the development of non-invasive diagnostic approaches, molecular stratification of patients, and the identification of potential therapeutic targets. Further investigation of the prognostic value of molecular markers and their associations with the clinical characteristics of endometriosis may contribute to individualized patient management.

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (39)

Source provenance

openalex
last seen: 2026-11-20T06:09:37.170340+00:00
License: CC0 · commercial use OK